VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
41 hedge funds and large institutions have $29.6M invested in VIVEVE MED INC in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
14% more funds holding
Funds holding: 36 → 41 (+5)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
37% less capital invested
Capital invested by funds: $47.1M → $29.6M (-$17.5M)
78% less call options, than puts
Call options by funds: $4K | Put options by funds: $18K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$8.01M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$6.32M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.67M |
| 4 |
RI
RTW Investments
New York
|
+$3.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.69M |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.04M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$447K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$262K |
| 4 |
Squarepoint
New York
|
-$132K |
| 5 |
ECM
Element Capital Management
New York
|
-$103K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$2.4K | +1 | New |
|
VIVE Hedge Fund Activity: Q4 2018 in Review
41 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2018, worth a combined $29.6M — down 37% from $47.1M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VIVE positions and 9 closed out — a net gain of 5 holders — while 9 added to existing stakes and 11 trimmed.
The largest buyer was Hood River Capital Management, opening a new position worth an estimated $8.01M. The largest seller was Stonepine Capital Management, cutting an estimated $1.04M.
- 41 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2018, up from 36 in Q3 2018.
- Funds reported $29.6M of VIVEVE MED INC stock for Q4 2018, down 37% quarter-over-quarter.
- 14 funds opened new VIVEVE MED INC positions in Q4 2018 and 9 closed out, a net change of +5 holders.
- The largest VIVEVE MED INC buyer in Q4 2018 was Hood River Capital Management, an estimated $8.01M added.
- The largest VIVEVE MED INC seller in Q4 2018 was Stonepine Capital Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q4 2018.